TIMP1 and Hepatic fibrosis: CsA and NIM811 administered to CCl4-treated rats lowered liver fibrosis, alanine aminotransferase, inflammation, transforming growth factor-β, tissue inhibitor of metalloproteinase-1, and other markers (Lie et al., 1991; Wang et al., 2011).